LONDON - Oncimmune Holdings PLC (AIM: ONC.L), a company specializing in autoantibody profiling for the pharmaceutical and biotechnology sectors, has announced the scheduling of a General Meeting (GM) ...

A team from Osaka University has developed scSPOT, a new technique that reveals how immune cells called Tregs simultaneously ...

A complementary drug to combat Alzheimer’s disease could target a specific part of the nerve cell protein tau.

Nature Medicine has been chronicling advances in medical technology and health care. To mark the journal’s 30th anniversary, each month ...

Vimentin is a type III intermediate filament (IF) protein normally expressed in cells that develop into connective tissue, ...

BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, today announced a collaboration with BeiGene Ltd., a global oncology company that intends to change its name to ...

US-based biotech company Epicore Biosystems has secured $26m in Series B funding led by the Steele Foundation for Hope aiming ...

Dana-Farber Cancer Institute researchers will present important research studies during the 2025 ASCO Genitourinary (GU) ...

Epicore Biosystems announced today that it raised a $26 million Series B round to support its biowearable technologies.